Today Sep 22, 2021
Event Image
Back to Events

VNS Therapy® and ECT in Treatment-Resistant Depression (TRD)*

Friday Sep 10, 2021
Event Time 04:55 - 05:55 PM ET
Registration Closed
Event Faculty

Harold Sackeim PhD

Professor of Psychiatry and Radiology
Columbia University
Chief of Biological Psychiatry
New York State Psychiatric Institute
Event Faculty

Charles Conway MD

Director, Treatment-Resistant Depression
Neurostimulation Clinic
Director, Washington University Center for the Advancement of Research in Resistant Mood and Affective Disorders (CARRMA)
Interventional Psychiatry Rotation Director
St. Louis, MO

Program Description
A webinar presentation by Doctors Sackeim and Conway on the utilization of VNS therapy in TRD.

Learning Objectives
To educate physicians on VNS Therapy and the RECOVER Clinical Trial. In addition to providing details on the MOA of Vagus Nerve Stimulation, we will underscore the ability to combine VNS and ECT, as well as provide an overview of the RECOVER trial.

*The VNS Therapy System is indicated for the adjunctive long-term treatment of chronic or recurrent depression for patients 18 years of age or older who are experiencing a major depressive episode and have not had an adequate response to four or more adequate antidepressant treatments. Please see Important Safety Information.

Event Sponsors

Product Theater sponsored by LivaNova during the 8th Annual Mood Disorders Summit.